Systematic Review
Accepted on 24 Apr 2025
Gastric cancer radiation therapy: A bibliometric analysis of the scientific literature Authors：
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1513255
Type at least 3 characters
30,844 articles
Original Research
Accepted on 24 Apr 2025
High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin 51
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1590073
Systematic Review
Accepted on 24 Apr 2025
Chemotherapy Cardiotoxicity Research in Cancer Patients: A bibliometric and visual analysis(1994-2024)
in Radiation Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1502361
Case Report
Accepted on 24 Apr 2025
CASE REPORT: ORAL LICHENOID MUCOSITIS IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING TREATMENT WITH PEMBROLIZUMAB AND AXITINIB
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1495446
Case Report
Accepted on 24 Apr 2025
Extranodal NK/T-cell lymphoma, nasal type-a case report and a review of the literature
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1560442
Clinical Trial
Accepted on 24 Apr 2025
Neoadjuvant toripalimab combined with chemotherapy in locally advanced HNSCC Author
in Head and Neck Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1571776
Case Report
Accepted on 24 Apr 2025
A case of new-onset retroperitoneal aggressive fibromatosis after resection of solid pseudopapillary tumor of the pancreas and review of the literature
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1522860
Correction
Published on 24 Apr 2025
Corrigendum: Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response early
in Cancer Metabolism
Frontiers in Oncology
doi 10.3389/fonc.2025.1588290
Original Research
Published on 24 Apr 2025
Expression of SMURF family in pancreatic cancer and its effect on cell proliferation and migration
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1538335
- 101 views
Original Research
Published on 24 Apr 2025
Efficacy and safety of TACE combined with TKIs and PD-1 inhibitors in HCC patients with prior TIPS
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1570029
Original Research
Published on 24 Apr 2025
Prognostic role of inflammatory and tumor biomarkers in hilar cholangiocarcinoma patients receiving postoperative adjuvant therapy
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Frontiers in Oncology
doi 10.3389/fonc.2025.1555369
Original Research
Published on 24 Apr 2025
High expression of SOX10 is correlated with poor prognosis and immune infiltrates in skin cutaneous melanoma
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1444670
- 122 views
Original Research
Published on 24 Apr 2025
Deep learning in assisting dermatologists in classifying basal cell carcinoma from seborrheic keratosis
in Skin Cancer
Frontiers in Oncology
doi 10.3389/fonc.2025.1507322
- 127 views
Original Research
Published on 24 Apr 2025
Impact of primary cancer history and molecular landscape in therapy-related myeloid neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2025.1563990
- 145 views
Case Report
Published on 24 Apr 2025
Case Report: Two cases of chemotherapy refractory aggressive variant prostate cancer with extreme durable response to PARP inhibitor
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1533627
Case Report
Published on 24 Apr 2025
Case Report: Severe brigatinib-induced pneumonitis in a patient with EML4–ALK+ metastatic non-small cell lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1572425